Atorvastatin

CD4 molecule ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34825359 Atorvastatin restores imbalance of cluster of differentiation 4 (CD4)+ T cells in immune thrombocytopenia in vivo and in vitro. 2021 Nov 25 1
2 25441397 Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial. 2015 Mar 2
3 25740578 Changes of naturally occurring CD4(+)CD25(+) FOXP3(+) regulatory T cells in patients with acute coronary syndrome and the beneficial effects of atorvastatin treatment. 2015 1
4 21297491 Effect of oral atorvastatin on CD4+CD25+ regulatory T cells, FoxP3 expression, and prognosis in patients with ST-segment elevated myocardial infarction before primary percutaneous coronary intervention. 2011 May 2
5 21325137 High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial. 2011 Mar 15 1
6 19247848 Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis. 2009 1
7 19332119 Ezetimibe and atorvastatin both immunoregulate CD4+ T cells from cardiac transplant recipients invitro. 2009 Jul 4
8 17826781 The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. 2008 Apr 4
9 17100774 Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis. 2006 Dec 1